The Team in A Nutshell : Dr. Haim Ezer
The Team in A Nutshell : Dr. Haim Ezer
The Team in A Nutshell : Dr. Haim Ezer
Assaf Harel
Technology and innovation enthusiastic, entrepreneur; has 20 years
experience in the IT industry, half of them in the healthcare industry
developing PACS and patientcare innovative solutions (Medcon, acquired
by Mckesson and MedCPU).
Prior to AneuScreen held various R&D managerial and leadership roles;
founded Quiksee in 2004 (Acquired by Google in 2010) and Checkmarx
in 2006 (information security company, part of Insight Ventures portfolio).
What is AneuScreen?
• A novel screening procedure for the future
development of cerebral aneurysms
• The result of a six years translational research
• Aneurysms rupture is uncommon, however, the
huge economic burden, makes it cost effective to
screen the entire population.
• This screening test identifies individuals at risk,
for the future development of cerebral
aneurysms.
• Those expected to develop an aneurysm are
assigned to a semi annual follow up regime.
Cerebral aneurysms, a primer
• An out-bulging from
cerebral arteries.
• Ruptures in 30000
Americans annually.
• Average age at rupture is
57.
• Horrible prognosis!
Cerebral aneurysms, a primer - cont.
• Small percentage, ~ 15% will have
“good” results.
• Half a million individuals die each
year due to aneurysms rupture,
internationally.
• http://www.ninds.nih.gov/disorders/cerebral_aneurysm/detail_cerebral_aneurysms.htm#259673098
Cerebral aneurysms, current Tx. options
MRA reconstruction
Business Model